Lipella Pharmaceuticals
PITTSBURGH, Pennsylvania, United States · Biopharma, Biotechnology, Healthcare
Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. We are also applying our proprietary drug delivery to the oral mucosa for the treatmen
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- PITTSBURGH, Pennsylvania, United States
- Employees
- 5
- Industries
- Biopharma, Biotechnology, Healthcare
- Status
- Public (LIPO)
- Website
- lipellapharmaceuticals.com
- Company page
Recent activity at Lipella Pharmaceuticals
- : SEC 8-K (1.03):
- : SEC 8-K (1.03): On March 30, 2026, Lipella Pharmaceuticals Inc. and certain of its subsidiaries filed voluntary petitions for relief under Chapter 11 in the Bankruptcy Court for the Western District of Pennsylvania. This filing indicates that the company is undergoing a bankruptcy process, which poses substantial risks to its shareholders. As the company is now in Chapter 11, trading in its common stock is considered highly speculative, and there could be a significant disconnect between stock prices and potential recoveries for shareholders in the bankruptcy proceedings.
- : SEC 8-K (5.02): On February 3, 2026, Lori A. Birder notified Lipella Pharmaceuticals Inc. of her resignation from the Company's Board of Directors, effective immediately. Dr. Birder's resignation was not due to any disagreements with the Company regarding its operations, policies, or practices. This change in the board composition could impact the governance and strategic direction of Lipella Pharmaceuticals in the near term.
Employee benefit plans
Lipella Pharmaceuticals files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Lipella Pharmaceuticals: questions and answers
What does Lipella Pharmaceuticals do?
Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. We are also applying our proprietary drug delivery to the oral mucosa for the treatmen
Where is Lipella Pharmaceuticals headquartered?
Lipella Pharmaceuticals is headquartered in PITTSBURGH, Pennsylvania, United States.
How many employees does Lipella Pharmaceuticals have?
Lipella Pharmaceuticals has about 5 employees.
What is the latest news on Lipella Pharmaceuticals?
On Jul 15, 2026, SEC 8-K (1.03):
Is Lipella Pharmaceuticals a public company?
Yes. Lipella Pharmaceuticals is publicly traded under the ticker LIPO.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy